Suncare Sundays: Skin Cancer Facts
Every day in the US more than 9500 people will be diagnosed with skin cancer. More people are diagnosed with skin cancer each year in the U.S than all other cancers combined. The earlier skin cancer is detected and treated, the better chance of a cure.
1 in 5 Americans will develop skin cancer by the age of 70.
More than 2 people die of skin cancer in the U.S. every hour.
Having 5 …
Every day in the US more than 9500 people will be diagnosed with skin cancer. More people are diagnosed with skin cancer each year in the U.S than all other cancers combined. The earlier skin cancer is detected and treated, the better chance of a cure.
1 in 5 Americans will develop skin cancer by the age of 70.
More than 2 people die of skin cancer in the U.S. every hour.
Having 5 … 
Skin of Color Update, the largest medical education event focused on the dermatologic treatment of patients with skin of color, is expanding in 2021 with an additional half day of programming and pre-conference symposium. The event will be held virtually September 10-12 with the symposium on August 3.
“The expanded program will allow us to address even more topics and provide more in-depth co … 
What should this patient be evaluated for?
A. Deafness
B. Cataracts
C. Neurocutaneous melanosis
D. Limb length discrepancy
E. Brachydactyly
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
Dermatology KOLs Adam Friedman, MD and Joel L. Cohen, MD, and Heather Onorati, former dermatology magazine editor and managing editor for Pathogens and Immunity journal, share their expert advice on becoming a go-to media expert in the dermatology
When Adam Friedman, MD, began his dermatology career, he made the most of every media opportunity that came his way. He sent reporters scientific pap … 
INTRODUCTION
Palbociclib is one of three new small-molecule inhibitors of cyclin-dependent kinase 4 and 6 (CDK4/6) approved for use in the treatment of hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (Her2-) advanced or metastatic breast cancer. CDK4/6 inhibitors have a good overall safety profile but reported side effects include cytopenias, diarrhea, QTc pr …